Callan Family Office’s Novanta NOVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$947K Buy
8,018
+1,638
+26% +$215K 0.02% 576
2025
Q4
$759K Buy
6,380
+2,538
+66% +$289K 0.02% 630
2025
Q3
$385K Sell
3,842
-1,275
-25% -$152K 0.01% 622
2025
Q2
$660K Buy
5,117
+2,031
+66% +$247K 0.02% 500
2025
Q1
$395K Buy
3,086
+41
+1% +$5.89K 0.03% 376
2024
Q4
$465K Buy
+3,045
New +$516K 0.03% 382

Other funds holding NOVT

Callan Family Office's NOVT Position: Q1 2026 in Review

Callan Family Office increased its Novanta (NOVT) stake by 26% in Q1 2026, buying an estimated $215K and bringing the position to 8,018 shares worth $947K. The position accounts for 0.02% of the portfolio, ranked #576.

Callan Family Office first reported a position in NOVT in Q4 2024 and has held it in 6 quarters since. 329 funds tracked by Wall St. Rank hold NOVT as of Q1 2026.

  • Callan Family Office held 8,018 shares of Novanta worth $947K as of Q1 2026.
  • Callan Family Office bought 1,638 Novanta shares in Q1 2026, an estimated $215K.
  • Novanta made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #576 holding.
  • Callan Family Office first reported a position in Novanta in Q4 2024 and has held it in 6 quarters since.
  • 329 funds tracked by Wall St. Rank held Novanta as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.